Tianjin Medical University Reports Findings in Norovirus (A quadrivalent norovirus vaccine based on a chimpanzee adenovirus vector induces potent immunity in mice).

A recent report from Tianjin Medical University in China discusses the development of a potential quadrivalent norovirus vaccine. Norovirus is a common cause of gastroenteritis worldwide, and there are currently no approved vaccines for clinical use. The researchers used a chimpanzee adenovirus vector to carry the major capsid protein of noroviral genotypes GI and GII. The vaccine, administered via intranasal delivery, induced high levels of antibodies and stimulated cell-mediated immune responses in mice. This novel vaccine shows promise for further development as a preventive measure against norovirus. [Extracted from the article]

Copyright of Food Weekly News is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)